6533b86dfe1ef96bd12ca1f2

RESEARCH PRODUCT

Pregnancy in an azoospermic patient with markedly elevated serum follicle-stimulating hormone levels

Antonio PellicerYolanda MinguezCarmen RubioManuel Gil-salomJosé Remohí

subject

AdultMaleendocrine systemmedicine.medical_specialtyMicroinjectionsmedicine.drug_classmedicine.medical_treatmentFertilization in VitroBiologyIntracytoplasmic sperm injectionAndrologyFollicle-stimulating hormonePregnancyInternal medicineTestismedicineHumansMicroinjectionAzoospermiaPregnancySertoli CellsIn vitro fertilisationurogenital systemObstetrics and GynecologyOligospermiamedicine.diseaseSpermatozoaEndocrinologyReproductive MedicineOocytesFemaleFollicle Stimulating HormoneGonadotropinSpermatogenesis

description

Objective To assess the possibility of achieving a pregnancy in an azoospermic patient with markedly elevated serum FSH level. Design A case report. Setting In vitro fertilization program at the Instituto Valenciano de Infertilidad. Patient An azoospermic patient with small testes and serum FSH level (38.7 mlU/mL) higher than three times normal. Testicular biopsy revealed Sertoli cell-only syndrome with focal spermatogenesis. Interventions Intracytoplasmic microinjection of testicular tissue-extracted spermatozoa. Main Outcome Measurements: Fertilization rate, cleavage rate, clinical pregnancy. Results Eight of 11 (73%) intact oocytes showed two pronuclei. All of them cleaved normally. Four embryos were replaced into the uterine cavity and the other four were cryopreserved. A twin clinical pregnancy was achieved. Conclusion Spermatozoa may be present in testicular biopsy specimens of azoospermic patients with severe spermatogenic failure despite markedly elevated serum FSH level. These patients can be fertile after intracytoplasmic testicular sperm microinjection.

https://doi.org/10.1016/s0015-0282(16)57991-6